Skip to content
Roundtable

Report

The longevity boom is getting ahead of the science

Al Jazeera EnglishOpinion

Longevity biotechnology has drawn billions in investment amid growing interest from world leaders, but the science behind extending human lifespan remains far from delivering on that ambition. Researchers have identified twelve interconnected "hallmarks of ageing" at the cellular level, yet no proven treatment exists to meaningfully slow or reverse the ageing process.

Read the full report at aljazeera.com